Landscapes / Targets
NMDA receptor
8 drugs act on NMDA receptor, in 16 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs8
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | Dec 2027Phase 3 trial completes | |||
| Next date | Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Major Depressive Disorder, Smoking Cessation | ||||
| Open drug page | |||||
— |
Phase 3 | May 2027Phase 3 trial completes | |||
| Next date | May 2027 · Phase 3 trial completes | ||||
| Also tested for | GRIN-related Disorders, Tuberous Sclerosis Complex and 4 more | ||||
| Open drug page | |||||
— |
Phase 2/3 | 31 Dec 2027Phase 2/3 trial completes | |||
| Next date | 31 Dec 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Treatment Resistant Depression, Treatment Resistant Depression (TRD) | ||||
| Open drug page | |||||
Xenonnot checked |
— |
Phase 3 | Apr 2029Phase 3 trial completes | ||
| Next date | Apr 2029 · Phase 3 trial completes | ||||
| Also tested for | Post-Cardiac Arrest Syndrome | ||||
| Open drug page | |||||
— |
Phase 2 | Sep 2027Phase 2 trial completes | |||
| Next date | Sep 2027 · Phase 2 trial completes | ||||
| Also tested for | Major Depressive Disorder | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Mild Cognitive Impairment, Mild Dementia and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Alzheimer Disease | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Major Depressive Disorder, Healthy Volunteer | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 7 of 8 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026